Hahn Pledges FDA Independence While Maintaining Role On Warp Speed

FDA Commissioner Stephen Hahn will participate in discussions or considerations of Operation Warp Speed, but won’t be involved in specific decisions or recommendations of the COVID-19 countermeasures public-private partnership to preserve agency independence, he said. The approach is less black and white than other agency officials, but may be acceptable given a commissioner’s more limited role in specific product reviews. Still, some worried about lines becoming blurred. 

FDA Commissioner Stephen Hahn
FDA Commissioner Stephen Hahn doesn't have a formal role on Warp Speed but will be involved in the COVID-19 project

US Food and Drug Administration Commissioner Stephen Hahn said he will not make any decisions for Operation Warp Speed, the country’s public-private effort to accelerate access for the US to a COVID-19 vaccine and therapetuics. The move is part of Hahn’s effort to maintain his and the agency’s regulatory independence during COVID-19, but the commissioner isn’t fully stepping back from Warp Speed, leading to mixed opinions about whether that independence will be fully realized.

“We have been very clear in writing and also verbally that we will maintain our regulatory independence. So Janet [Woodcock]...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

PS-AgencyLeadership (Premium-1): Study Reveals How Immune System of Astronauts Breaks Down

Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.

Nancy Test Circulable Section Geography

 

This is a short description

test-sabbah

 
• By 

Test -Sabbah

Akash test for clone

 
• By 

Test article to check the clone issue

More from Pink Sheet

COVID Vaccines: US FDA Changes Course, Wants New Formulas To Target KP.2 Subvariant ‘If Feasible’

 
• By 

Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’

Nancy Tests New Podcast Template

 

Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.

PinkSheet-R&D-Free: ‘Ranking’ article that includes different Composer content

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.